In this podcast episode, Sarah M. Tinsley, PhD, APRN, AOCN, discusses management strategies for secondary AML and novel therapies currently in clinical trials for AML. Topics include:

• Liposomal cytarabine plus daunorubicin for secondary AML
• An overview of emerging immune-based strategies for AML
• Evidence on immune-based therapies, including agents targeting CD47, TIM3, and bispecific antibodies

Presenter:

Sarah M. Tinsley, PhD, APRN, AOCN
Nurse Practitioner
Courtesy Assistant Professor
Department of Malignant Hematology
Moffitt Cancer Center
University of South Florida
Tampa, Florida

 

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.